← 返回 Skills 市场
Alexion
作者
hanxueyuan
· GitHub ↗
· v1.0.1
· MIT-0
102
总下载
0
收藏
1
当前安装
2
版本数
在 OpenClaw 中安装
/install alexion
功能描述
Specializes in rare disease drugs using complement inhibition, building a $10B franchise led by Soliris and acquired by AstraZeneca in 2021.
使用说明 (SKILL.md)
Alexion — 罕见病药物专家
历史时间线
- 1992: Leonard Bell 在康涅狄格创立 Alexion
- 1990s-2000s: 专注于补体系统研究
- 2007: Soliris（依库珠单抗）获批，首个补体抑制剂
- 2011-2019: Soliris 成为全球最昂贵药物之一（年定价 $70 万+）
- 2019: Ultomiris 获批——Soliris 的升级版
- 2021: AstraZeneca 以 $390 亿收购 Alexion
- 2023: 补体抑制剂组合贡献 AstraZeneca 约 $60 亿营收
商业模式
罕见病药物——超高定价 + 长生命周期。Soliris 覆盖 PNH、aHUS 等罕见适应症，每个患者年均治疗费用 $70-80 万。
护城河分析
补体抑制剂领域的先发优势——10+ 年的独占专利。罕见病患者群体小但付费意愿极强（保险公司覆盖）。AstraZeneca 的渠道整合加速了全球扩张。
关键数据
- 被 AstraZeneca 以 $390 亿收购
- Soliris 累计营收超 $300 亿
- Ultomiris 年营收约 $40 亿
- 全球约 2 万名患者受益
有趣事实
Soliris 上市时的年定价超过 $70 万美元，被称为"全球最贵药物"。但其临床价值巨大——将 PNH 患者的死亡率从 50% 降至接近零。Alexion 的创始人 Bell 曾说："我们不是在高价卖药，我们是在卖生命。"
安全使用建议
This skill is low-risk and appears to be a content-only reference about Alexion and complement inhibitors. Before installing, note the source is unknown — verify any clinical, financial, or pricing claims against primary sources if you plan to act on them. Monitor future updates: if a later version adds installs, network access, or required credentials, re-evaluate before trusting it. If you need verified clinical guidance, prefer official publications or regulatory documents rather than a third-party skill summary.
功能分析
Type: OpenClaw Skill
Name: alexion
Version: 1.0.1
The skill bundle contains purely informational content regarding Alexion Pharmaceuticals, including its history, business model, and acquisition by AstraZeneca. There is no executable code, network activity, or prompt injection attempts within SKILL.md or _meta.json.
能力评估
Purpose & Capability
Skill name and description (rare-disease/complement inhibition specialist) match the SKILL.md content (timeline, business model, facts). It does not request unrelated resources or capabilities.
Instruction Scope
SKILL.md contains factual/background content and a short read_when list — it does not instruct the agent to read files, access environment variables, call external endpoints, or perform actions outside summarizing/answering on the topic.
Install Mechanism
No install spec and no code files are present (instruction-only). Nothing is written to disk or downloaded, minimizing installation risk.
Credentials
No environment variables, credentials, or config paths are required. The skill does not ask for secrets or unrelated tokens.
Persistence & Privilege
always is false and the skill is user-invocable; autonomous model invocation is allowed (platform default) but the skill has no capabilities that would expand risk if invoked autonomously.
如何使用
- 确保已安装 OpenClaw（本地或 Docker 部署）
- 在对话框中输入安装命令：
/install alexion - 安装完成后，直接呼叫该 Skill 的名称或使用
/alexion触发 - 根据 Skill 的参数说明提供必要输入，即可获得结构化输出
版本历史
v1.0.1
- Added a new version header (version: 1.0.0) to SKILL.md for clarity and version control.
- No other content changes were made.
v1.0.0
- Added a comprehensive summary of Alexion, the rare disease specialist acquired by AstraZeneca for $39B.
- Included a historical timeline highlighting key milestones, drug approvals, and financial achievements.
- Detailed the commercial model focusing on rare disease drug pricing and patient impact.
- Provided a moat analysis explaining Alexion's dominance in complement inhibition and global expansion strategy.
- Listed essential company data and interesting facts about drug pricing and clinical impact.
元数据
常见问题
Alexion 是什么？
Specializes in rare disease drugs using complement inhibition, building a $10B franchise led by Soliris and acquired by AstraZeneca in 2021. 它是一个面向 Claude Code / OpenClaw 的 AI Agent Skill 插件，目前累计下载 102 次。
如何安装 Alexion？
在 OpenClaw 或 Claude Code 对话框中运行命令「/install alexion」即可一键安装，无需额外配置。
Alexion 是免费的吗？
是的，Alexion 完全免费，采用 MIT-0 许可证，可自由下载、安装和使用。
Alexion 支持哪些平台？
Alexion 跨平台运行，可在任意部署了 OpenClaw / Claude Code 的环境中使用（cross-platform）。
谁开发了 Alexion？
由 hanxueyuan（@hanxueyuan）开发并维护，当前版本 v1.0.1。
推荐 Skills